Soy isoflavone: The multipurpose phytochemical (Review)

  • Authors:
    • Qinglu Wang
    • Xiaoyue Ge
    • Xuewen Tian
    • Yujun Zhang
    • Jie Zhang
    • Pingping Zhang
  • View Affiliations

  • Published online on: June 3, 2013     https://doi.org/10.3892/br.2013.129
  • Pages: 697-701
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Soy isoflavones are compounds found in soybean and soybean products. They have been reported to possess numerous physiological properties, such as antitumor, anti-menopausal (female) osteoporosis and anti‑aging. They have also been reported to improve learning and memory skills in menopausal women and aid in the prevention and treatment of heart disease, diabetes and Kawasaki disease (KD). In this review, the effects of soy isoflavones on various diseases were analyzed. Based on the analysis, it was hypothesized that the function of soybean isoflavones in the prevention and treatment of various diseases results from their phytoestrogen and antioxidant properties. However, due to their phytoestrogen properties, it is recommended that the risks of soy isoflavone intake as food and̸or medical treatment be further evaluated.

References

1 

Messina M: A brief historical overview of the past two decades of soy and isoflavone research. J Nutr. 140:S1350–S1354. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Kao TH and Chen BH: Functional components in soybean cake and their effects on antioxidant activity. J Agric Food Chem. 54:7544–7555. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Kao TH, Huang RFS and Chen BH: Antiproliferation of hepatoma cell and progression of cell cycle as affected by isoflavone extracts from soybean cake. Int J Mol Sci. 8:1095–1110. 2007. View Article : Google Scholar

4 

Kao TH, Wu WM, Hung CF, Wu WB and Chen BH: Anti-inflammatory effects of isoflavone powder produced from soybean cake. J Agric Food Chem. 55:11068–11079. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Dalais FS, Ebeling PR, Kotsopoulos D, McGrath BP and Teede HJ: The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf). 58:704–709. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Migliaccio S and Anderson JJ: Isoflavones and skeletal health: are these molecules ready for clinical application? Osteoporos Int. 14:361–368. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Farina HG, Pomies M, Alonso DF and Gomez DE: Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep. 16:885–891. 2006.PubMed/NCBI

8 

Wada K, Nakamura K, Tamai Y, et al: Soy isoflavone intake and breast cancer risk in Japan: From the Takayama study. Int J Cancer. Feb 6–2013.(Epub ahead of print). View Article : Google Scholar

9 

Boucher BA, Cotterchio M, Anderson LN, Kreiger N, Kirsh VA and Thompson LU: Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk. Int J Cancer. 132:1439–1450. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Zhang YF, Kang HB, Li BL and Zhang RM: Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev. 13:479–482. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Satoh H, Nishikawa K, Suzuki K, et al: Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent. Res Commun Mol Pathol Pharmacol. 113–114:149–158. 2003.PubMed/NCBI

12 

Xie Q, Chen ML, Qin Y, et al: Isoflavone consumption and risk of breast cancer: a dose-response meta-analysis of observational studies. Asia Pac J Clin Nutr. 22:118–127. 2013.PubMed/NCBI

13 

Akaza H, Miyanaga N, Takashima N, et al: Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol. 32:296–300. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M and Tsugane S: Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 16:538–545. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Perabo FG, Von Low EC, Ellinger J, von Rucker A, Muller SC and Bastian PJ: Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 11:6–12. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Sugiyama Y, Masumori N, Fukuta F, et al: Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev. 14:1–4. 2013. View Article : Google Scholar : PubMed/NCBI

17 

File SE, Jarrett N, Fluck E, Duffy R, Casey K and Wiseman H: Eating soya improves human memory. Psychopharmacology (Berl). 157:430–436. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Bone HG, Greenspan SL, McKeever C, et al: Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab. 85:720–726. 2000.PubMed/NCBI

19 

Gallagher JC: The pathogenesis of osteoporosis. Bone Miner. 9:215–227. 1990. View Article : Google Scholar

20 

Wei P, Liu M, Chen Y and Chen DC: Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med. 5:243–248. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Verhaeghe J, van Bree R, Van Herck E, et al: Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. J Bone Miner Res. 11:1723–1735. 1996. View Article : Google Scholar : PubMed/NCBI

22 

Nielsen TF, Ravn P, Bagger YZ, Warming L and Christiansen C: Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int. 15:168–174. 2004.PubMed/NCBI

23 

Seeman E: Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr Osteoporos Rep. 2:90–96. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Celec P, Ostatnikova D, Caganova M, et al: Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol Obstet Invest. 59:62–66. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E and Bressel MA: Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 10:196–202. 2003. View Article : Google Scholar : PubMed/NCBI

26 

Lephart ED, West TW, Weber KS, et al: Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol Teratol. 24:5–16. 2002. View Article : Google Scholar

27 

Lund TD, West TW, Tian LY, et al: Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci. 2:202001. View Article : Google Scholar : PubMed/NCBI

28 

Lee YB, Lee HJ, Won MH, et al: Soy isoflavones improve spatial delayed matching-to-place performance and reduce cholinergic neuron loss in elderly male rats. J Nutr. 134:1827–1831. 2004.PubMed/NCBI

29 

Bang OY, Hong HS, Kim DH, et al: Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis. 16:21–28. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Behl C: Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol. 57:301–323. 1999.

31 

Holscher C: Possible causes of Alzheimer’s disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Dis. 5:129–141. 1998.

32 

Morris JC: Dementia update 2003. Alzheimer Dis Assoc Disord. 17:245–258. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Ramassamy C, Averill D, Beffert U, et al: Oxidative insults are associated with apolipoprotein E genotype in Alzheimer’s disease brain. Neurobiol Dis. 7:23–37. 2000.PubMed/NCBI

34 

Zeng H, Chen Q and Zhao B: Genistein ameliorates beta-amyloid peptide (25–35) -induced hippocampal neuronal apoptosis. Free Radic Biol Med. 36:180–188. 2004.PubMed/NCBI

35 

Pan Y, Anthony M and Clarkson TB: Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med. 221:118–125. 1999. View Article : Google Scholar : PubMed/NCBI

36 

Xi YD, Li XY, Ding J, et al: Soy isoflavone alleviates Aβ1–42-induced impairment of learning and memory ability through the regulation of RAGE/LRP-1 in neuronal and vascular tissue. Curr Neurovasc Res. 10:144–156. 2013.

37 

Tikkanen MJ and Adlercreutz H: Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol. 60:1–5. 2000. View Article : Google Scholar : PubMed/NCBI

38 

Beavers DP, Beavers KM, Miller M, Stamey J and Messina MJ: Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 22:182–191. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Yamakoshi J, Piskula MK, Izumi T, et al: Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr. 130:1887–1893. 2000.PubMed/NCBI

40 

Chan YH, Lau KK, Yiu KH, et al: Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J. 29:2800–2807. 2008. View Article : Google Scholar : PubMed/NCBI

41 

Gilbert ER and Liu D: Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function. Food Funct. 4:200–212. 2013.PubMed/NCBI

42 

Behloul N and Wu G: Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol. 698:31–38. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P and Colleoni M: The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur J Pharmacol. 650:694–702. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Chiang HS, Wu WB, Fang JY, et al: UVB-protective effects of isoflavone extracts from soybean cake in human keratinocytes. Int J Mol Sci. 8:651–661. 2007. View Article : Google Scholar

45 

Chiu TM, Huang CC, Lin TJ, Fang JY, Wu NL and Hung CF: In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. J Ethnopharmacol. 126:108–113. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Assefa Z, Van Laethem A, Garmyn M and Agostinis P: Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim Biophys Acta. 1755:90–106. 2005.PubMed/NCBI

47 

Portman MA: Kawasaki disease and soy: potential role for isoflavone interaction with Fcgγ receptors. Pediatr Res. 73:130–134. 2013.PubMed/NCBI

48 

Safe S: Endocrine disruptors and human health: is there a problem. Toxicology. 205:3–10. 2004. View Article : Google Scholar : PubMed/NCBI

49 

Paganetto G, Campi F, Varani K, Piffanelli A, Giovannini G and Borea PA: Endocrine-disrupting agents on healthy human tissues. Pharmacol Toxicol. 86:24–29. 2000. View Article : Google Scholar

50 

Wuttke W, Jarry H, Becker T, et al: Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas. 44(Suppl 1): S9–S20. 2003. View Article : Google Scholar : PubMed/NCBI

51 

Helferich WG, Andrade JE and Hoagland MS: Phytoestrogens and breast cancer: a complex story. Inflammopharmacology. 16:219–226. 2008. View Article : Google Scholar : PubMed/NCBI

52 

Chen A and Rogan WJ: Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu Rev Nutr. 24:33–54. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2013
Volume 1 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Q., Ge, X., Tian, X., Zhang, Y., Zhang, J., & Zhang, P. (2013). Soy isoflavone: The multipurpose phytochemical (Review). Biomedical Reports, 1, 697-701. https://doi.org/10.3892/br.2013.129
MLA
Wang, Q., Ge, X., Tian, X., Zhang, Y., Zhang, J., Zhang, P."Soy isoflavone: The multipurpose phytochemical (Review)". Biomedical Reports 1.5 (2013): 697-701.
Chicago
Wang, Q., Ge, X., Tian, X., Zhang, Y., Zhang, J., Zhang, P."Soy isoflavone: The multipurpose phytochemical (Review)". Biomedical Reports 1, no. 5 (2013): 697-701. https://doi.org/10.3892/br.2013.129